Clinical and Research Advancements in Corona Virus

A. Gulia
{"title":"Clinical and Research Advancements in Corona Virus","authors":"A. Gulia","doi":"10.36648/2386-5180.21.9.337","DOIUrl":null,"url":null,"abstract":"In case of global pandemic corona virus disease 2019, clinical trials and research are assessing efficacy and safety for clinical patients for treating covid-19 as, it is evolving at unprecedented rate, by tracking clinical trials done and avoiding duplication efforts and phase2 clinical trials evaluate new therapeutics and by including investigational therapeutic effort on synthetic monoclonal antibodies (mAbs) for treating disease. Trials designed to elaborate test multiple different kind of monoclonal antibody treatment.","PeriodicalId":8195,"journal":{"name":"Annals of Clinical and Laboratory Research","volume":"30 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Clinical and Laboratory Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36648/2386-5180.21.9.337","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In case of global pandemic corona virus disease 2019, clinical trials and research are assessing efficacy and safety for clinical patients for treating covid-19 as, it is evolving at unprecedented rate, by tracking clinical trials done and avoiding duplication efforts and phase2 clinical trials evaluate new therapeutics and by including investigational therapeutic effort on synthetic monoclonal antibodies (mAbs) for treating disease. Trials designed to elaborate test multiple different kind of monoclonal antibody treatment.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
冠状病毒的临床与研究进展
就2019年全球大流行冠状病毒病而言,临床试验和研究正在评估治疗covid-19的临床患者的有效性和安全性,因为它正在以前所未有的速度发展,跟踪已完成的临床试验并避免重复工作,第二阶段临床试验评估新疗法,并包括用于治疗疾病的合成单克隆抗体(单克隆抗体)的研究性治疗工作。试验旨在详细测试多种不同种类的单克隆抗体治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Research and Recent Advancements on Multiple Sclerosis Emerging Public Health Threats and their Health Perspectives Immunology and Multiple Sclerosis Risk with Air Pollution Seroprevalence of Cytomegalovirus among Schizophrenic Patients in Khartoum State Short Communication on Anesthesiology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1